Kostmann syndrome is a hematologic disorder characterized by a maturation arrest of myelopoiesis. This arrest results in severe neutropenia leading to absolute neutrophil counts (ANC) below 0.2 × 10 9 /l associated with severe bacterial infections.
describing successful BMT in the setting of fungal infections, the option of BMT is not well-established in patients with pre-existing bacterial infections, particularly with myeloablative conditioning. This is probably because bacterial infections are usually more aggressive than fungal infections. We describe a patient with pre-transplant pulmonary abscesses which resolved after unrelated HLA-matched BMT.
Case report
A 5-year-old girl with Kostmann syndrome was admitted to the Mie University Hospital for unrelated BMT. She was first hospitalized with pneumonia at the age of 1 day. The peripheral white blood cell (WBC) count was 5.3 × 10 9 /l with no neutrophils. Bone marrow aspirate showed maturation arrest of myelopoiesis at the promyelocyte stage which was compatible with the diagnosis of Kostmann syndrome. Over the next 4 years, she suffered frequent infections. She responded to appropriate antibiotic therapy initially. There was no increase in circulating neutrophils during infections or after treatment with various doses of G-CSF, or after longer administration of 5-100 g/kg/day for up to 10 days. She developed a pulmonary abscess in the left lower lobe confirmed by chest computed tomography (CT) scans when she was 4 years of age. Because of the severity and frequency of infections, she was scheduled for BMT. On admission, she had a high fever and cough. The WBC count was 4.9 × 10 9 /l (1% neutrophil, 47% monocytes, 49% lymphocytes, and 2% eosinophils). Bone marrow aspiration revealed normoplastic marrow with an apparent maturation arrest between promyelocytes and myelocytes, and no malignant transformation, myelodysplasia or cytogenetic abnormalities. Laboratory findings included increased C-reactive protein (10.8 mg/dl, normally Ͻ0.30), normal ␤-d-glucan level (sensitivity for fungal infection, 90%). 5 Latex agglutination test for serum Aspergillus antigen (sensitivity, 78.6% using Pastrex Aspergillus, Diagnostics Pasteur, Paris, France) 6 and serum Candida antigen (sensitivity, 69% using Cand-Tec, Ramco Labs Inc, Houston, TX, USA) 7 were negative. Complement fixation for serum Aspergillus antibody 8 was negative (sensitivity, 91%). These assays for fungal infections were performed by BML Inc., Tokyo, Japan. Throat, sputum, and stool cultures showed overgrowth of methicillin-resistant Staphylococcus aureus (MRSA; MIC Ͼ32 g/ml). Repeated blood cultures were negative for bacteria and fungi. Cultures from other parts of the body gave no growth of pathogenic bacteria or fungi, but only normal flora. Mantoux tuberculin skin test was negative. Viral studies, including cytomegalovirus and Epstein-Barr virus, were negative. She was diagnosed as having a pulmonary abscess due to MRSA. She was treated with G-CSF (lenograstim) 300-500 g/m 2 /day, vancomycin and an aminoglycoside antibiotic, arbekacin, which is stable in the presence of the aminoglycoside-inactivating enzymes produced by MRSA. Sputum cultures may not be diagnostic for intractable pulmonary abscesses. To identify the pathogenic organisms causing the abscesses and to render the patient microbiologically 'sterile' prior to entering a transplant programme, a date for surgical removal of the pulmonary abscess was scheduled. However, just before the operation day, chest CT scans showed that the abscess in the left lower lobe had gradually increased in size and an additional one had developed in the right upper lobe. Although bronchoalveolar lavage or biopsy were desirable to establish the causative organism, it was decided that these were too risky. She had commenced large doses of antibiotics, antifungal agents (intravenous fluconazole and/or oral itraconazole), and human urinary macrophage colony-stimulating factor (M-CSF) eight million unit/day for 24 days. M-CSF enhances differentiation of progenitor cells to mature monocytes, stimulates chemotactic, phagocytic and killing activities of the monocyte, and prolongs monocyte survival. In addition, M-CSF stimulates production of several cytokines such as G-CSF and interleukin-8, and assists neutrophil functions. 9 After starting M-CSF, her cough and fever subsided, although the neutrophil count did not increase and the pulmonary abscesses remained essentially unchanged on CT scan. It was decided to undertake BMT in spite of the persistence of the pulmonary abscesses. A family donor was not available. Informed consent was obtained from the parents, and the patient was transplanted from an unrelated HLA-matched female donor (4.3 × 10 8 /kg). The preparative regimen consisted of 12-Gy total body irradiation (TBI) with lung shielding, from day −9 to day −6 (six fractions), 5 mg/kg antithymocyte globulin i.v. daily from day −5 to day −2, 50 mg/kg etoposide i.v. on day −5, and 40 mg/kg cyclophosphamide i.v. daily from day −4 to day −2. Marrow ablation appears effective in Kostmann syndrome. 4 Cyclosporin A (CsA) and methotrexate were used for graftversus-host disease (GVHD) prophylaxis. Engraftment was confirmed on day 21 after BMT, when the WBC reached 1.3 × 10 9 /l with 60% neutrophils. Thirty-eight days after BMT, acute GVHD (skin, grade I) appeared and was successfully treated with increased CsA doses. She had no granulocyte transfusions pre-or post-transplant. The pulmonary abscesses resolved completely by day 75 post-transplant (Figure 1 ), although no specific changes had been made to the antibiotic and antifungal regimen, suggesting a pivotal role of neutrophils in the treatment of the pulmonary abscesses. She was well, and discharged with 100% Karnofsky performance status. She has been in good condition for the last 23 months following BMT.
Discussion
Zeidler et al 4 reported 11 patients with Kostmann syndrome who underwent stem cell transplantation. Of the 11 patients, three were transplanted from non-HLA matched related donors (two from a single-antigen-mismatched and one from an antigen-mismatched) and two of them died of infectious complications or GVHD. The eight patients who underwent transplantation from an HLA-identical sibling survived. In the present case, it is less likely that recovery from the infection would have occurred with conventional antibiotics and G-CSF/M-CSF unless a normal neutrophil count had been restored by BMT. Since this patient did not have an HLA-identical sibling, she received an unrelated HLA-matched transplant. Although there is potential toxicity and risk with stem cell transplantation from a non-HLA-identical sibling, 4 we emphasize that unrelated HLAmatched BMT is an alternative when an HLA-matched sibling is not available.
Infectious complications are the major cause of mortality following BMT and there are many organisms which may cause pulmonary abscesses in the setting of immunodeficiency. 10 In the present case, the laboratory findings included raised CRP, normal ␤-d-glucan levels, and negative Aspergillus antigen and antibody. Throat, sputum, and stool cultures showed overgrowth by MRSA. Cultures from other parts of the body yielded only normal flora. In cases of invasive pulmonary aspergillosis, the conventional treatment consists of high-dose amphotericin B, surgery, and granulocyte transfusions. Since the present case recovered from the pulmonary abscesses without amphotericin B, Aspergillus infection is very unlikely. Based on these findings, we diagnosed this case as having pulmonary abscesses secondary to MRSA, although there was no positive culture available from bronchopulmonary lavage or a surgical specimen. Pulmonary abscesses due to MRSA have been described. 11 Irradiation itself has a significant effect on oropharyngeal flora, and Abu Shara et al 12 reported that Staphylococcus aureus may significantly increase after irradiation. Every effort should be made to ensure patients are rendered microbiologically 'sterile' prior to entering a transplant programme. However, there are several reports concerning pre-transplant infections. Despite myeloablative conditioning therapy, pre-transplant fungal infections should not necessarily rule out the possibility of BMT if they can be successfully controlled. 13 Agematsu et al 14 reported a case of pre-transplant pneumonia who received a non-myeloablative conditioning regimen. However, there are no reports of pre-transplant bacterial infections where a myeloablative conditioning regimen was used. In cases of myeloablative conditioning, infections may develop either as a result of marrow failure or persistent immunologic dysfunction following bone marrow recovery. In spite of having received myeloablative conditioning, the present case recovered from the pulmonary bacterial abscesses without exacerbation of the infection. We therefore suggest that BMT could be considered in patients with Kostmann syndrome who do not respond to conventional antibiotics and G-CSF therapy, even in the setting of severe pre-transplant infection. 
